No Data
No Data
No Data
No Data
No Data
Express News | PDS Biotech To Event To Discuss Positive, Updated Data From Phase 2 VERSATILE-002 Clinical Trial With Versamune HPV In Combination With KEYTRUDA In Recurrent Or Metastatic Head And Neck Cancer
Moomoo 24/7Apr 23 08:01 ET
PDS Biotechnology Corporation's (NASDAQ:PDSB) Market Cap Dropped US$1.5m Last Week; Individual Investors Who Hold 59% Were Hit as Were Institutions
Yahoo FinanceMar 30 08:35 ET
PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript
Yahoo FinanceMar 28 10:15 ET
Noble Financial Sticks to Its Buy Rating for PDS Biotechnology (PDSB)
TipRanksMar 28 08:25 ET
B. Riley Securities Adjusts PDS Biotechnology's Price Target to $11 From $14, Maintains Buy Rating
B. Riley Securities Adjusts PDS Biotechnology's Price Target to $11 From $14, Maintains Buy Rating.
MT NewswiresMar 28 07:57 ET
PDS Biotechnology: Strategic Shift to Triplet Therapy Promises Enhanced Clinical Success
TipRanksMar 28 07:25 ET
No Data
No Data
全力買い : バイオおすすめありますか?